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The humoral arm of the immune response is a 
crucial element of adaptive immunity that in-
volves antibody (Ab) production by plasma cells 
(PCs). PCs differentiate from B cells when acti-
vated in a T cell–dependent or –independent 
manner. T cell–dependent B cell activation is a 
tightly regulated process that includes germinal 
center (GC) formation, in which affinity matu-
ration through somatic hypermutation, isotype 
switching, and the generation of memory cells 
take place. Dysregulation of the GC reaction 
can lead either to humoral immunodeficiency 
or to severe autoimmune disorders. Indeed, pa-
tients suffering from systemic lupus erythema-
tosus (SLE), a potentially fatal autoimmune 
disease, show augmented GC formation lead-
ing to the production of auto-Abs attacking 
various tissues.
The GC reaction is conducted by highly 
specialized CD4+ T lymphocytes called follicu-
lar T helper (TFH) cells (Crotty, 2011). They 
provide cognate help to GC–B cells (Crotty, 
2011). TFH cells depend on the expression of 
the chemokine receptor CXCR5 and down-
regulation of the chemokine receptor CCR7 
to facilitate repositioning from T cell zones into 
B cell follicles, directly promoting GC immune 
responses (Ma et al., 2012). CXCR5 (CD185 
or Burkitt lymphoma receptor 1) is a G protein–
coupled seven transmembrane receptor for 
chemokine CXCL13, which is strongly ex-
pressed in the follicles of the spleen, lymph 
nodes, and Peyer’s patches. Besides CXCR5, 
TFH cells are characterized by the expression 
of various surface molecules, such as ICOS, 
CD40L, PD-1, and BTLA, and the massive pro-
duction of IL-21 (Chtanova et al., 2004; Rasheed 
et al., 2006).
The differentiation into Th subtypes like Th1, 
Th2, Th9, and Th17 is directed by signature 
transcription factors. Accordingly, TFH cells rep-
resenting a distinct subset are reliant on a specific 
transcription factor, namely B cell lymphoma-6 
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Maturation of high-affinity B lymphocytes is precisely controlled during the germinal 
center reaction. This is dependent on CD4+CXCR5+ follicular helper T cells (TFH) and inhib-
ited by CD4+CXCR5+Foxp3+ follicular regulatory T cells (TFR). Because NFAT2 was found to 
be highly expressed and activated in follicular T cells, we addressed its function herein. 
Unexpectedly, ablation of NFAT2 in T cells caused an augmented GC reaction upon immu-
nization. Consistently, however, TFR cells were clearly reduced in the follicular T cell popula-
tion due to impaired homing to B cell follicles. This was TFR-intrinsic because only in these 
cells NFAT2 was essential to up-regulate CXCR5. The physiological relevance for humoral 
(auto-)immunity was corroborated by exacerbated lupuslike disease in the presence of 
NFAT2-deficient TFR cells.
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the GC reaction, i.e., the number of GC-B cells and the 
quantity and quality of secreted immunoglobulins, by direct 
repression of B cells (Lim et al., 2005; Wollenberg et al., 2011; 
Sage et al., 2013).
Foxp3+ nTreg cells localize to diverse tissues by the expres-
sion of the relevant homing receptors and suppress various 
cell types to avoid autoimmunity. To do so they adapt to part 
of the transcriptional program of the very cells they suppress 
(Josefowicz et al., 2012). Accordingly, TFR cells express Bcl-6, 
which is required for CXCR5 expression (Johnston et al., 
2009; Yu et al., 2009; Kroenke et al., 2012). However, as men-
tioned, Bcl-6 alone is not sufficient for CXCR5 expression, 
suggesting that additional transcription factors are involved in 
this process. NFAT2, highly expressed in both TFH and GC-B 
cells, seemed like an unlikely candidate because we had found 
that NFAT2-deficient nTreg cells not only express Foxp3 nor-
mally but are also fully suppressive (Vaeth et al., 2012). Nev-
ertheless, when we studied the impact of T cell– or even 
Treg-specific ablation of NFAT2, we observed an increased 
and pathogenic GC reaction, which was dominated by the 
altered homing behavior of NFAT2-deficient TFR cells into 
B cell follicles. This could be attributed to the absolute de-
pendence on NFAT2 for CXCR5 expression in TFR cells 
being TFR-specific and intrinsic. Therefore, a subset of Treg cells, 
namely that of TFR cells, does depend on a single member of 
NFAT, not for their general suppressor function, which is very 
much in line with our former data (Vaeth et al., 2012), but for 
proper tissue localization. This is of significance to disease be-
cause NFAT2-deficient TFR cells failed to control humoral auto-
immunity, as demonstrated in a model of murine SLE.
RESULTS
NFAT2 is strongly expressed  
and activated in follicular T cells
Because we had observed that NFAT2 has especially high 
expression in human TFH cells (Rasheed et al., 2006), we ad-
dressed the expression of NFAT transcription factors in their 
murine counterparts. Microarray experiments revealed en-
hanced RNA expression of NFAT1 in CD4+ICOShiCXCR5hi 
TFH compared with activated CD4+ICOShiCXCR5– T cells 
and/or CD4+ICOS–CXCR5– naive conventional T (Tconv) 
cells, but the family member most clearly up-regulated was 
NFAT2 (Fig. 1 A). Alternate definition of TFH cells by 
CD4+PD-1hiCXCR5hi in comparison to CD4+PD-1–CXCR5– 
Tconv cells revealed the same dominance of NFAT2 by qRT-
PCR, which was primarily caused by high Nfat2 P1 promoter 
activity (Fig. 1 B). More importantly, the P1 promoter was 
also more effective in CD4+PD-1hiCXCR5hi TFH cells than 
in activated CD4+ICOShi Tconv cells (Fig. 1 B, lower graphs). 
Making use of BAC-transgenic Nfatc1/egfp reporter mice 
(Bhattacharyya et al., 2011; Hock et al., 2013), TFH cells (de-
fined as CD4+PD-1hiCXCR5hi or CD4+ICOShiCXCR5hi) 
from KLH- or SRBC-immunized mice exhibited the highest 
green fluorescence (Fig. 1 C and not depicted). This was re-
flected by the strong nuclear appearance of NFAT2, similar to 
that found in activated Tconv cells (Fig. 1 D). Corresponding to 
(Bcl-6; Johnston et al., 2009; Yu et al., 2009; Kroenke et al., 
2012). Importantly, Bcl-6 not only inhibits key transcription 
factors for Th1 and Th17, namely Tbx21 and Rorc expression 
(Yu et al., 2009), but also represses B lymphocyte-induced 
maturation protein (Blimp-1), which attenuates the develop-
ment of TFH cells and subsequently GC responses (Johnston 
et al., 2009). Ectopic overexpression of Bcl-6 leads to the ex-
pression of CXCR5, although Bcl6 has not been demon-
strated to transactivate Cxcr5 or Il21 directly (Yu et al., 2009; 
Kroenke et al., 2012). Because deletion of c-Maf, BATF, or IRF4 
almost completely abrogated TFH cell generation (Bauquet 
et al., 2009; Kwon et al., 2009; Ise et al., 2011; Bollig et al., 
2012), the involvement and interrelation with other transcrip-
tional regulators is likely. As the transcription of nuclear factor 
of activated T cells (NFAT) is strongly enhanced in TFH cells 
(Rasheed et al., 2006) and NFAT cooperates with c-Maf and 
IRF4 (Ho et al., 1996; Rengarajan et al., 2002a; Farrow et al., 
2011), NFAT proteins could be likewise involved.
The family of NFAT transcription factors consists of 
four Ca2+-responsive members, known as NFAT1/NFATc2, 
NFAT2/NFATc1, NFAT3/NFATc4, and NFAT4/NFATc3 
(Serfling et al., 2000; Müller and Rao, 2010). Upon TCR ini-
tiated Ca2+ influx and the subsequent activation of calmodulin/
calcineurin, preformed NFAT1/NFAT4 are dephosphory-
lated and translocated into the nucleus, where they bind to 
GGA motifs (usually those with 3-adenine tracts). Although 
most NFAT factors, including the long isoforms of NFAT2, 
are constitutively expressed, the shortest isoform of NFAT2, 
i.e., NFAT2/A, is induced in effector cells through an auto-
regulatory mechanism that involves NFAT binding to the 
Nfat2 P1 promoter (Chuvpilo et al., 2002; Serfling et al., 
2012). Despite functional redundancies among individual NFAT 
members, which can consequently lead to a more severe im-
pairment when two NFAT proteins are deleted (Peng et al., 
2001; Rengarajan et al., 2002b; Vaeth et al., 2012), individ-
ual NFAT members also serve distinct roles. Therefore, single 
NFAT-deficient mice as well as exogenously expressed mem-
bers or even their individual isoforms display divergent phe-
notypes (Nayak et al., 2009; Müller and Rao, 2010; Serfling 
et al., 2012).
As a precisely controlled process, the GC reaction involves 
various regulatory cell types. Notably, impaired function of 
thymus-derived natural Foxp3+ (nTreg) T cells (Sakaguchi et al., 
2008) escalates GC responses, leading to the production of 
pathogenic auto-Abs and SLE in patients (Valencia et al., 2007; 
Bonelli et al., 2008, 2010). Accordingly, a special subset of 
nTreg cells that share characteristics with TFH cells, follicular 
regulatory T (TFR) cells, was identified in GCs (Chung et 
al., 2011; Linterman et al., 2011; Wollenberg et al., 2011). 
Similar to TFH cells, TFR cells express CXCR5, ICOS, and 
PD-1, but in addition, they exhibit typical Treg markers, such 
as Foxp3, CD25, GITR, and CTLA4 (Chung et al., 2011; 
Linterman et al., 2011; Wollenberg et al., 2011). Furthermore, 
TFR cells not only express Bcl-6, but also high levels of Blimp-1, 
a known Foxp3 target gene (Zheng et al., 2007; Johnston et al., 
2009; Linterman et al., 2011). They limit the magnitude of 
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Figure 1. Expression and activation of NFAT2 in follicular T cells. (A) Microarray analysis of Nfat expression in FACS-sorted CXCR5–ICOS– (Tnaiv),  
CXCR5–ICOShi (Tact), and CXCR5hiICOShi (TFH) CD4+ T cells of KLH-immunized mice; 3 independent experiments with 12 mice per group. (B, top) qRT-PCR for Nfat2, 
Nfat1, Nfat4, and Nfat2 promoter P1 (exon 1 to exon 3) and P2 (exon 2 to exon 3) expression in CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) CD4+ T cells of KLH-
immunized mice. (bottom) qRT-PCR for Nfat2 promoter P1 and P2 expression of T cells sorted as in A from SRBC-immunized mice. (C) Flow cytometry of NFAT2 
expression in CXCR5–PD-1– (Tconv), CXCR5hiPD-1hi (TFH), CXCR5–ICOS– (Tnaiv), CXCR5–ICOShi (Tact), and CXCR5hiICOShi (TFH) CD4+ T cells using KLH-immunized Nfatc1/egfp 
BAC-tg reporter mice. (D) Confocal microscopy of NFAT2 and NFAT2/ nuclear localization in FACS-sorted CXCR5–PD-1– (Tconv), with or without activation over-
night by anti-CD3/28, and CXCR5hiPD-1hi (TFH) CD4+ T cells from KLH-immunized mice. (E) Confocal microscopy of NFAT1 and NFAT4 nuclear localization in FACS-
sorted CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) CD4+ T cells from KLH-immunized mice. (F) Histological analysis of NFAT2/ expression in follicular T cells of a 
chronically inflamed human tonsil (T cell zone = enriched for T cells; B cell follicle = fewer T cells; mantle zone = appearing dark due to no T cells). (G) Evaluation 
of NFAT2 RNA expression in human CXCR5hiICOShi (TFH) compared with CXCR5–ICOS–/lo (Tnaiv) and CXCR5loICOSint (Tact) CD4+ T cells, sorted from inflamed tonsils 
and analyzed by microarrays (three independent chip analyses per CD4+ T cell population, with each chip representing at least 3 donors; Rasheed et al., 2006). 
Values were normalized to Tnaiv for NFAT 1 and NFAT2, respectively. (B and G) Student’s t test: *, P < 0.05; **, P < 0.005; ***, P < 0.001.
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Treg cells in the population of Tconv versus TFH cells upon im-
munization. As NFAT2-sufficient and -deficient Tconv cells 
displayed the same number of Foxp3+ Treg cells, significantly 
fewer Foxp3+ TFR cells were detected among PD-1+CXCR5+ 
TFH cells in mice lacking NFAT2 (Fig. 4 A). This was true ir-
respective of the kind and strength of immunization, shown 
by immunization with NP-KLH or SRBCs as well as by Ova 
in Nfat2fl/fl x Cd4cre x OT-II mice tested by flow cytometry 
and, in individual follicles, by immunohistochemistry (Fig. 4, 
A–D; and not depicted). Confocal microscopy discovered re-
duced numbers of Foxp3+ TFR cells within PNA-positive 
GC-areas in Nfat2fl/fl x Cd4cre mice (Fig. 4 E). For compari-
son, we addressed the impact of NFAT1 on TFR cells. The num-
bers of TFR cells in B cell follicles of immunized Nfat1/ mice 
were found unaltered, whereas additional NFAT1 deficiency in 
Nfat2fl/fl x Cd4cre mice might further impair the frequency of 
TFR cells (Fig. 4, F and G). In summary, this defines NFAT2 as 
an important transcription factor for one specific subtype of 
nTreg cells, namely TFR cells, which are distributed mainly be-
tween B cells in GCs (unpublished data).
Impaired numbers of Foxp3+ TFR cells in B cell follicles  
is a NFAT2-regulated Treg-intrinsic effect
Earlier we demonstrated that the generation of thymus-
derived nTreg cells, to which TFR belong (Linterman et al., 
2011), does not depend on NFAT1 and NFAT2 in terms of 
Foxp3 expression (Vaeth et al., 2012). This was not consistent 
with the observed decrease of Foxp3+ cells within NFAT2-
deficient CXCR5hi TFH cell population. We therefore asked if 
the loss of Foxp3+ cells was Treg-intrinsic by crossing Nfat2fl/fl 
mice to Foxp3-IRES-Cre (FIC; Wing et al., 2008) mice and 
found, again, a profound reduction of CXCR5hi TFR cells 
upon immunization (Fig. 5 A). In line with our former find-
ings, no alteration of nTreg cell frequencies within the 
CD4+CXCR5–PD-1– Tconv population could be observed 
(Fig. 5 A). Immunohistochemistry confirmed fewer Foxp3+ 
TFR cells in reactive B cell follicles (Fig. 5 B). Comparable to 
the eradication of NFAT2 in all T cells, Treg-specific NFAT2 
deletion led to an augmented GC reaction (Fig. 5 C and not 
depicted) paralleled by an increase in antigen-specific IgM 
and IgG after immunization (Fig. 5 D). To exclude secondary 
effects caused by the influence of other cells, e.g., via IL-2 
production, we adoptively co-transferred WT and NFAT2-
deficient CD4+ T cells at a ratio of 1:1 into Rag1/ mice, 
followed by immunization (Fig. 5 E). WT T cells were distin-
guished by CD90.1 from CD90.2+ Nfat2/ T cells. Again, 
we found a decrease in TFR cells specifically within the 
CD90.2+ NFAT2-deficient T cell population (Fig. 5 E). The 
 phenotype achieved by T cell–specific loss of NFAT2 for 
the GC reaction was similar to a total depletion of Treg cells. 
This was performed by injection of diphtheria toxin into immu-
nized Foxp3DTR-eGFP mice (Lahl et al., 2007). Clearly reduced 
numbers of TFR cells were seconded by an expansion of GCs 
upon depletion of Treg cells (Fig. 5 F and not depicted). Over-
all, these data account for an NFAT2-dependent and TFR 
cell–intrinsic effect to limit humoral immune reaction.
the robust Nfat2 P1 activity, NFAT2/ isoforms were domi-
nantly expressed and activated in TFH like in Tconv cells. NFAT1 
and NFAT4 were also found to be activated in CD4+PD-1hi 
 CXCR5hi cells, but to a lesser extent (Fig. 1 E). Prominent 
NFAT2 and especially NFAT2/ expression was verified in 
human TFH cells in chronically inflamed tonsils (Fig. 1, F and G), 
conclusively confirming NFAT2 as robustly expressed and 
activated in human TFH cells (Rasheed et al., 2006).
NFAT2 deficiency in T cells causes  
an augmented GC reaction
Next, we tested the consequence of T cell–specific NFAT2 
ablation for the GC reaction Nfat2fl/fl x Cd4cre mice are 
healthy and show a fairly normal composition of lymphoid 
compartments (Vaeth et al., 2012). Nonetheless, we detected 
modest but considerably increased frequencies of TFH cells in 
spleen and mesenteric LNs (mLNs) from NP-KLH–immunized 
Nfat2fl/fl x Cd4cre mice compared with Cd4cre littermates 
being significant over the complete distribution of the data-
sets (Fig. 2, A and B). By PNA staining of histological sec-
tions, however, we observed an even more clearly pronounced 
GC response (Fig. 2 C and not depicted). Flow cytometry re-
inforced a boosted frequency of B220+GL-7+Fas+ GC-B cells 
in NP-KLH– or SRBCs-immunized Nfat2fl/fl x Cd4cre mice 
(Fig. 2 D and not depicted). Consecutively, the titer of the 
NP-specific Abs IgM and class-switched IgG1 and IgG3 was 
increased in Nfat2fl/fl x Cd4cre mice upon NP-KLH immuni-
zation (Fig. 2 E), revealing an overall amplification of the GC 
reaction upon loss of NFAT2 in T cells.
There are fewer Foxp3+ TFR cells  
among NFAT2-deficient CXCR5hi follicular T cells
To unravel the increase in GC reaction in Nfat2fl/fl x Cd4cre 
mice at the molecular level, we performed global transcrip-
tion analyses of FACS sorted ICOShiCXCR5hi TFH cells in 
comparison to activated (ICOShiCXCR5–) and naive (ICOS–
CXCR5–) Tconv cells. In line with highest expression of NFAT2 
in TFH cells, NFAT2-deficient TFH cells showed prevalence in 
the number of differently regulated transcripts (Fig. 3, A and B). 
We analyzed affected transcripts and found that Treg-specific 
or –associated genes (Hill et al., 2007) were a self-contained 
group being reduced in Nfat2fl/fl x Cd4cre mice (Fig. 3 C). Per-
forming quantitative RT-PCR from NFAT2-sufficient and 
NFAT2-deficient TFH in comparison to Tconv cells again dem-
onstrated a clear transcriptional decline of two tested key 
molecules for TFR, namely Foxp3 and Blimp-1, whereas Bcl-6 
was slightly increased, if quantities changed at all (Fig. 3 D). 
The additional loss of NFAT1 in follicular T cells had no 
major impact, suggesting NFAT2 as the prominent NFAT 
family member in TFR cells (Fig. 3 D).
T cell–specific NFAT2 deficiency results  
in fewer TFR cells within B cell follicles
Because microarray analyses of CD4+ICOShiCXCR5hi TFH cells 
revealed a reduction in the Treg cell signature (Hill et al., 2007) 
upon NFAT2 deficiency, we tested the frequency of Foxp3+ 
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and CD4+ICOShiCXCR5hi TFH subsets from WT and Nfat2fl/fl x 
Cd4cre mice, the decrease in TFR cells was paralleled by an in-
crease in nTreg cells within the CD4+ICOShiCXCR5– (Tact) 
population (Fig. 6 A). This was a particular feature of NFAT2 
and not affected by NFAT1 deficiency in Foxp3+ Treg cells of 
an activated CD4+CD44hi phenotype (Fig. 6 B). Because 
CXCR5 is the essential homing receptor for TFH and TFR cells, 
CXCR5 expression is selectively impaired  
in NFAT2-deficient Foxp3+ Treg cells
As Foxp3 expression is independent on NFAT factors in 
thymus-derived nTreg cells (Vaeth et al., 2012), we reasoned that 
NFAT2-deficient nTreg cells might be unable to home to GCs. 
Indeed, when evaluating the frequency of Foxp3+ cells in naive 
CD4+ICOS–CXCR5– or activated CD4+ICOShiCXCR5– Tconv 
Figure 2. NFAT2 deficiency in T cells causes 
augmented GC reaction upon immunization. 
(A) Representative flow cytometry of splenic 
CD4+CXCR5hiPD-1hi TFH cells from WT and Nfat2fl/fl x 
Cd4cre mice 10 d after KLH immunization (left), 
plus compilation of 12 independent experiments 
(right). (B) Analysis of splenic CD4+CXCR5–ICOShi 
(Tact) and CD4+CXCR5hiICOShi (TFH) population of 
WT and Nfat2fl/fl x Cd4cre mice 10 d after KLH 
immunization. (C) PNA staining of mLNs from WT 
and Nfat2fl/fl x Cd4cre mice 10 d after KLH immu-
nization (top). Bars, 250 µm. Quantification of 
PNA-positive GC areas (bottom left) and percent-
age of PNA-positive follicles per mLN (bottom 
right) from 5 individual mice; PBS ctrl., mice re-
ceived only PBS. (D) Representative flow cytom-
etry of splenic and mLN GC-B cells from WT 
littermate and Nfat2fl/fl x Cd4cre mice 10 d after 
KLH immunization (left), plus synopsis of 12 inde-
pendent experiments (right). (E) ELISA of NP-
specific IgM, IgG1, and IgG3 antibodies in sera  
of WT and Nfat2fl/fl x Cd4cre mice before (non-
immune) and after 10 d of NP-KLH immuni-
zation; each dot represents one individual mouse.  
(A and C–E) Student’s t test: *, P < 0.05;  
**, P < 0.005.
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Figure 3. Global transcription analysis of NFAT2-deficient T cell subsets reveals reduced Foxp3+ Treg frequencies within follicular T cells.  
(A) Venn diagram illustrating the overlap of differentially expressed genes in CXCR5–ICOS– (Tnaiv), CXCR5–ICOShi (Tact), and CXCR5hiICOShi (TFH) CD4+ T cells 
from WT and Nfat2fl/fl x Cd4cre mice after immunization with KLH for 7 d. Differentially expressed genes (≥2-fold regulated; P < 0.05) were identified by 
comparing WT cells to their Nfat2fl/fl x Cd4cre counterparts. (B) Clustering analysis and heatmap of gene expression in T cell subsets as in A. The heat map 
illustrates the log2 transformed expression intensity of genes that are at least twofold regulated between the populations and a p-value ≤ 0.05 for the 
effect of genotype. (C) Heatmap of Treg-specific or –associated genes that are differentially expressed (≥2-fold; P < 0.05) between WT and NFAT2-deficient 
CD4+CXCR5hiICOShi TFH cells. (A–C) Data are derived from 3 independent experiments with 12 mice per group and experiment. (D) qRT-PCR analysis of 
Foxp3, Prdm1, and Bcl6 expression in FACS-sorted CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) CD4+ T cells from KLH-immunized WT, Nfat2fl/fl x Cd4cre, 
and Nfat2fl/fl x Cd4cre x Nfat1/ mice; 2 independent experiments each with 4 mice per group (two-way ANOVA: *, P < 0.05; **, P < 0.005).
we evaluated whether its expression differs in WT and 
NFAT2-deficient T cells. Therefore, we defined follicular 
T cells as CD4+BTLAhi and found that NFAT2 selectively 
regulates CXCR5 expression in TFR but not in TFH cells 
(Fig. 6 C). In line with a TFR cell–specific effect, transwell ex-
periments suggested an impairment (although highly variable 
and therefore not significant) of NFAT2-deficient Foxp3+ 
nTreg cells, but not Tconv cells from immunized littermate 
mice in migration toward a CXCL13 gradient (Fig. 6 D). 
Altogether, these data indicate that Foxp3+ nTreg cells speci-
fically depend on NFAT2 expression for the up-regulation 
of CXCR5.
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Figure 4. Impaired homing to B cell follicles of NFAT2-deficient Foxp3+ regulatory T cells augments GC reaction. (A) Flow cytometry of Foxp3+ 
Treg frequency among CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) CD4+ T cell populations in spleen and mLNs from KLH-immunized WT and Nfat2fl/fl x Cd4cre 
mice (left), plus summary of eight individual experiments (right). (B) Histological examination of Foxp3+ Treg numbers in B cell follicles of KLH-immunized WT 
and Nfat2fl/fl x Cd4cre mice (left). Bars, 120 µm. Quantification of Foxp3+ cell numbers in follicles of four independent WT littermate and Nfat2fl/fl x Cd4cre 
littermates after KLH immunization (right); at least 10 follicles per individual spleen were analyzed. (A and B) Student’s t test *, P < 0.05; **, P < 0.005. (C) Rep-
resentative flow cytometry of Foxp3+ Treg cells among CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) splenic CD4+ T cell populations from SRBCs immunized WT 
and Nfat2fl/fl x Cd4cre mice. (D) Flow cytometry of Foxp3+ Treg cells among CXCR5–PD-1– (Tconv) and CXCR5hiPD-1hi (TFH) splenic CD4+ T cell populations from 
OVA-immunized OT-II and Nfat2fl/fl x Cd4cre x OT-II mice. (E) Confocal microscopy of Foxp3 (red), IgM (blue), and PNA-positive cells (green) in splenic GCs  
of KLH-immunized WT and Nfat2fl/fl x Cd4cre mice. Bars, 75 µm. (F) Flow cytometry of Foxp3+ Treg cell frequency among CD4+CXCR5hiPD-1hi TFH cell popula-
tion in spleens of KLH-immunized WT, Nfat2fl/fl x Cd4cre, Nfat1/, and Nfat2fl/fl x Cd4cre x Nfat1/ mice. (G) Flow cytometry of Foxp3+ Treg cells among 
CD4+ICOShiCXCR5hiTFH cells in spleens of KLH-immunized WT, Nfat2fl/fl x Cd4cre, Nfat1/, and Nfat2fl/fl x Cd4cre x Nfat1/ mice.
CXCR5-competent nTreg cells rescue  
the NFAT2-deficient phenotype
Although CXCR5 expression was clearly dependent on the 
presence of NFAT2, this could have been just one among 
many decisive reasons for a dysregulated GC reaction. In line 
with the notion that the observed defect laid within the nTreg 
compartment, adoptive transfer of in vitro anti-CD3/CD28-
activated congenic WT nTreg cells into immunized WT or 
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NFAT2 transactivates Cxcr5
Computational analyses of the TATA-less Cxcr5 promoter 
region revealed three conserved noncoding sequences (CNS) 
between men, dog, and mice with putative NFAT responsive 
elements (Fig. S1, A and B). Furthermore, two DNase hyper-
sensitive sites (HS1 and HS2) could serve as 3 enhancers 
(Fig. S1 C). Reporter gene assays in human Jurkat T or murine 
EL-4 thymoma cells using a 1,127-bp fragment of the Cxcr5 
promoter region containing most putative NFAT-responsive 
elements demonstrated inducibility and sensitivity to CsA 
(Fig. 8, A and B). Here, cells were activated by TPA plus 
ionomycin (T/I), which mimics antigen-receptor engagement. 
Nfat2fl/fl x Cd4cre recipient mice complemented the reduced 
number of TFR cells in NFAT2-deficient mice and rescued 
the GC phenotype (Fig. 7 A). Therefore, Nfat2/ nTreg cells 
were lentivirally transduced for CXCR5-GFP expression and 
adoptively transferred together with B cells and naive Tconv cells 
into Rag1/ mice, which were immunized 2 wk thereafter 
(Fig. 7 B). Pre-activated NFAT2-deficient (in parallel with 
NFAT2-sufficient) nTreg cells were successfully manipulated 
to express CXCR5 at their surface (Fig. 7 C). In fact, this 
made up for their NFAT2 deficiency during the provoked 
GC-reactions and restored GC-B cell numbers to normal 
levels (Fig. 7 D).
Figure 5. Impaired homing of Foxp3+ 
regulatory T cells to B cell follicles is a Treg 
cell–intrinsic, NFAT2-regulated defect.  
(A) Flow cytometry of Foxp3+ Treg cell fre-
quency among CXCR5–PD-1– (Tconv) and 
CXCR5hiPD-1hi (TFH) CD4+ T cell populations in 
spleen and mLN from KLH-immunized WT and 
Nfat2fl/fl x Foxp3-IRES-Cre (FIC) mice (left), 
plus summary of five independent experi-
ments (right). (B) Histological examination of 
Foxp3+ Treg numbers in B cell follicles of KLH-
immunized WT littermate and Nfat2fl/fl x FIC 
mice (left). Bars, 120 µm. Quantification of 
Foxp3+ cell numbers per follicle from three 
independent WT and Nfat2fl/fl x FIC littermates 
after KLH immunization (right). (C) Represen-
tative flow cytometry of splenic and mLN  
GC-B cells from WT and Nfat2fl/fl x FIC mice 10 d 
after KLH immunization. (D) ELISA of NP-
specific IgM and IgG antibodies in sera (three-
fold dilution steps starting from a 1:20 initial 
dilution) of WT and Nfat2fl/fl x FIC littermates 
after 10 d of NP-KLH immunization or PBS as 
control; 3 individual mice per group; n = 5  
for both ELISA. (E) Scheme of adoptive co-
transfer of 12 × 106 WT B cells, 6 × 106 CD90.1+ 
CD4+ WT T cells, and 6 × 106 CD90.1+ CD4+ 
Nfat2fl/fl x Cd4cre T cells into Rag1/ mice 
followed by KLH immunization (top). Repre-
sentative FACS analysis of Foxp3+ Treg cells 
within CD90.1+ or CD90.2+ population 
among CXCR5–PD-1– (Tconv) and CXCR5hi 
PD-1hi (TFH) CD4+ T cells in mLNs from Rag1/ 
hosts (bottom). (F) KLH immunization of WT 
and Foxp3DTR-eGFP (DEREG) mice followed  
by depletion of (follicular) Treg cells using 
diphtheria toxin (DT). Flow cytometry of  
CXCR5hiPD-1hi follicular T cells and GC-B cells. 
(A, B, and D) Student’s t test: *, P < 0.05;  
**, P < 0.005.
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Cxcr5-N4 as probes. Total protein extracts were prepared from 
transfections with an expression plasmid for the DNA-binding 
domain of NFAT2 (HA-Nc1-RSD; Klein-Hessling et al., 
2008)). The most proximal site (Cxcr5-N1) showed a similar 
bandshift as the Pubd from the Il2 promoter, but could not re-
spond to Blimp-1, which recognizes a similar core consensus 
sequence, namely GAAAG (Kuo and Calame, 2004). Cxcr5-N1 
The presence of HS2 slightly enhanced, but did not influence 
the quality of activity (Fig. 8 A). Within the Cxcr5 promoter 
three conserved regions (named as proximal, middle, and dis-
tal regions; Fig. S1, A and B) were defined, each containing 
putative NFAT-responsive elements (Fig. S1, B and D). To ad-
dress if NFAT can bind to these sites, we performed elec-
trophoretic mobility shift assays (EMSAs) using Cxcr5-N1 to 
Figure 6. Cxcr5 expression depends on NFAT2 only in TFR cells. (A) Flow cytometry of Foxp3+ Treg cells among CXCR5–ICOS– (Tnaiv),  
CXCR5– ICOShi (Tact), and CXCR5hiICOShi (TFH) mLN CD4+ T cells from KLH-immunized WT and Nfat2fl/fl x FIC mice. (B) Surface expression of CXCR5 on 
splenic CD4+CD44hiFoxp3+ Treg cells from KLH-immunized WT, Nfat2fl/fl x Cd4cre, and Nfat1/ mice. (C) Expression of CXCR5 on BTLAhiFoxp3+,  
BTLAloFoxp3+, BTLAhiFoxp3–, and BTLAloFoxp3– splenic CD4+ T cells of KLH-immunized WT and Nfat2fl/fl x Cd4cre littermates using flow cytometry; MFI of 
CXCR5 expression is quantified below (Student’s t test; **, P < 0.005). (D) Transwell assay of CD4+ T cells and CD4+Foxp3+ Treg cells in vitro (two indepen-
dent experiments; two-way ANOVA, ns). Total number of CD4+Foxp3+ Treg cells and CD4+Foxp3– Tconv cells from KLH-immunized WT littermate and  
Nfat2fl/fl x Cd4cre mice in the bottom transwell after 5-h incubation with various concentrations of CXCL13 (left). Phenotype of input and transwell cells 
after 5-h incubation with various concentrations of CXCL13 analyzed by flow cytometry (right).
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therefore assigns for a potent and specific NFAT-responsive 
element (Fig. 8 C). Using nuclear extracts from stimulated 
primary Treg cells corroborated the strong binding of NFAT 
to Cxcr5-N1. Both NFAT1 and NFAT2 could be recruited 
to this site as demonstrated by anti-NFAT1– and anti-NFAT2–
mediated supershifts (Fig. 8 D). Chromatin immunoprecipita-
tion (ChIP) assays using T cells from WT and Nfat2fl/fl x Cd4cre 
mice immunized with KLH verified the proximal part of the 
Cxcr5 promoter to be bound by NFAT2 in vivo (Fig. 8 E). To 
test the function of the Cxcr5-N1 site, we deleted distal parts 
of the Cxcr5 promoter and found that the proximal part alone 
(329 bp, containing Cxcr5-N1) could mediate T/I in-
duction in Jurkat cells (Fig. 8 F). Next, we mutated the two 
G-nucleotides of the Cxcr5-N1 motif essential for NFAT-binding 
within the 1,127-bp-long promoter fragment (NFAT-mutated). 
When nonlymphoid human embryonic kidney (HEK 293T) 
cells were transfected, we found that exogenous NFAT2 trans-
activated the Cxcr5 promoter robustly, but only when Cxcr5-N1 
was intact (Fig. 8 G and Fig. S1 D). In line with this, a signifi-
cantly reduced induction was witnessed in Jurkat cells, when 
this single NFAT-responsive element was mutated (Fig. 8 H). 
The same tendency was observed for the 329-bp fragment, as 
shown for EL-4 cells (Fig. 8 I). Overall, this demonstrated the 
important role of Cxcr5-N1 for NFAT2-mediated transacti-
vation of Cxcr5.
NFAT2-deficient TFR cells fail to control  
a lupuslike disease in chromatin-immunized mice
Patients suffering from SLE commonly exhibit increased fre-
quencies of TFH and GC-B cells and high titers of patho-
genic auto-Abs (Simpson et al., 2010), often correlated with 
impaired numbers and function of Treg cells (Valencia et al., 
2007; Bonelli et al., 2008, 2010). Clinical hallmarks of SLE 
are antinuclear antigen (ANA) and anti–double-stranded 
DNA (dsDNA) auto-Abs. Accordingly, immunization with 
chromatin isolated from syngeneic-activated lymphocytes 
leads to a lupuslike disease in mice (Li et al., 2004; Qiao et al., 
2005), which we performed with WT and Nfat2fl/fl x Cd4cre 
littermate mice (Fig. 9 A). Equivalent with all other im-
munizations, we observed a modestly increased number in 
CD4+CXCR5hiPD-1hi TFH cells (unpublished data), as well 
as GL-7hiFAShi GC-B cells and, importantly, a sharp drop in 
Figure 7. CXCR5-competent nTreg cells rescue the NFAT2-deficient 
phenotype. (A) Activated WT nTreg cells rescue the GC phenotype in 
NFAT2-deficient mice. Experimental layout transferring 5 × 106 anti-CD3/
CD28 activated CD90.1+ congenic WT nTreg cells in KLH-immunized 
CD90.2+ WT and Nfat2fl/fl x Cd4cre recipient mice (top). Analysis of host 
and donor TFR cells and GC-B cells in mice with or without adoptive  
transfer of 5 × 106 CD90.1+ nTreg cells using flow cytometry (bottom).  
(B–D) Lentiviral CXCR5 transduction of NFAT2-deficient nTreg cells rescues the 
GC phenotype. (B) Scheme of adoptive transfer experiments using CXCR5-
transduced WT and Nfat2fl/fl x Cd4cre nTreg cells. (C) Anti-CD3/CD28-
activated WT and NFAT2-deficient CD4+CD25hi nTreg cells were transduced 
with lentiviruses encoding for murine CXCR5-GFP or GFP only (EV, empty 
vector); 4 d later transduction efficiency was analyzed by flow cytometry. 
(D) Analysis of GC reaction in Rag1/ mice transferred with WT B cells 
and CD4+CD25–CD62Lhi T cells together with either mCXCR5-GFP– or 
EV-GFP–transduced WT and Nfat2fl/fl x Cd4cre nTreg cells. FACS-analysis  
21 d after transfer and 7 d after KLH immunization.
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chromatin-immunized mice exhibited enlarged splenic B cell 
follicles in Nfat2fl/fl x Cd4cre mice (unpublished data). Indica-
tive of a lupuslike disease, PAS-staining detected increased in-
tracapillary, mesangial hypercellularity and thickened contours of 
the frequency of TFR cells in spleen and mLN (Fig. 9 B and 
not depicted). Consequently, titers of pathogenic anti-dsDNA 
auto-Abs were found to be increased upon T cell–specific 
loss of NFAT2 (Fig. 9 C). PNA-immunohistochemistry of 
Figure 8. NFAT2 regulates Cxcr5 expression in T cells. (A) Luciferase assays of the Cxcr5 promoter and Cxcr5 promoter plus HS2. Transiently trans-
fected Jurkat cells were stimulated with T/I or T/I plus CsA; four independent experiments. Student’s t test: *, P < 0.05. (B) Luciferase assay as in A, but 
with EL-4 cells and the Cxcr5 promoter only; three independent experiments; Student’s t test: *, P < 0.05. (C) EMSA with whole cell extracts from 293T 
HEK cells transiently transfected with Ha-Nc1-RSD (35 kD) or Blimp-1-Flag (98 kD) and Il2-Pubd, Cxcr5-N1, Cxcr5-N2, Cxcr5-N3, or Cxcr5-N4 as probes 
(NFAT2, specific binding; *, unidentified band). (D) EMSAs with nuclear protein extracts from murine Treg cells harvested after 48 h of anti-CD3/CD28 plus 
IL-2 stimulation using the Cxcr5-N1 site as probe (position of NFAT-bound probe and antibody-supershifts [ss] are indicated). (E) ChIP analysis of NFAT2 
binding to the proximal, middle, and distal parts of the Cxcr5 promoter and the Il2 promoter containing Pubd. WT and Nfat2fl/fl x Cd4cre mice were immu-
nized with KLH for 7 d and splenic CD4+ T cells were used; two-way ANOVA: *, P < 0.05; **, P < 0.005; ***, P < 0.001. (F) Luciferase assays of full-length 
Cxcr5 promoter (1,127) and truncated versions (690 and 329). Transiently transfected Jurkat cells were stimulated with T/I or T/I plus CsA; 4 inde-
pendent experiments; Student’s t test: *, P < 0.05. (G) Luciferase assays of full-length Cxcr5 promoter (1,127) of WT or mutated proximal Cxcr5-N1 
NFAT motif (NFAT-mutated). HEK 293T cells were transiently co-transfected with empty vector or a NFAT2/C construct; 6 independent experiments; two-
way ANOVA: *, P < 0.05; **, P < 0.005. (H) Luciferase assays of full-length Cxcr5 promoter (1,127) of WT or mutated proximal Cxcr5-N1 NFAT motif 
(NFAT-mutated). Transiently transfected Jurkat cells were stimulated with T/I; 4 independent experiments; Student’s t test: *, P < 0.05. (I) Luciferase assays 
of the proximal Cxcr5 promoter (329) of WT or mutated proximal Cxcr5-N1 NFAT motif (NFAT-mutated). EL-4 cells were transiently transfected with 
empty vector or an NFAT2/C construct and stimulated with T/I or T/I plus CsA; 3 independent experiments; two-way ANOVA, n.s.
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the specific high expression of NFAT2 in GC-B, TFH, and, 
concomitantly, in TFR cells is another example of transcrip-
tion factor cooption allowing Treg cells to suppress distinct 
immune responses (Josefowicz et al., 2012).
So far, Bcl-6, which is obligatory for GC-B and TFH cells, 
had been designated as the coopting transcription factor in 
TFR cells, as it is mainly responsible for CXCR5 expression 
(Chung et al., 2011; Linterman et al., 2011; Josefowicz et al., 
2012). However, ectopic expression of Bcl-6 is insufficient to 
drive CXCR5 expression (Ma et al., 2012). Strikingly, trans-
ferred naive CD4+ T cells from Bcl6/ mice exhibit the same 
CXCR5 induction as WT cells, although TFH cells depend on 
Bcl-6 for a stable lineage commitment (Liu et al., 2012). Be-
cause Bcl-6 acts as a repressor, it instead intervenes with the 
transcriptional fate of other CD4+ T cell lineages; e.g., it antag-
onizes GATA3 expression and Th2 responses (Kusam et al., 
2003) and Tbx21 and Rorc expression (Yu et al., 2009), or binds 
and inhibits T-bet protein (Oestreich et al., 2012). Therefore, 
follicular T cell specificity is provided indirectly by Bcl-6.
Currently, little is known about the transcriptional con-
trol of Cxcr5 in TFH and TFR cells. In mature B cells, consti-
tutive expression is cooperatively regulated by Oct-2, Bob1 
(OBF-1), and NF-B, which bind to consensus sequences 
within its proximal promoter (Wolf et al., 1998). In addition, 
a putative NFAT-responsive element (Pu.box) was recog-
nized. Indeed, in retinoic acid–treated HL-60 cells, the human 
homologous element binds NFAT4 (Wang and Yen, 2004). 
However, we could not detect any binding of NFAT pro-
teins to the murine Cxcr5-N3. Another putative site, Cxcr5-N2, 
is essential for NF-B responsiveness in B cells (Wolf et al., 
1998), in line with a high degree of overlap between NFAT 
and NF-B sites (McCaffrey et al., 1994). Importantly, the 
most proximal and thus far unrecognized Cxcr5-N1 proofed 
to be a true and decisive NFAT response element. Therefore, 
NFAT2 is likely to contribute to CXCR5 expression in GC-B 
and TFH cells.
The fact that only TFR, but not TFH cells depend on 
NFAT2 to migrate to GCs attributes to the special transcrip-
tional landscape of nTreg cells. Effector Treg (eTreg) cells, which 
have differentiated in parallel with their respective Tconv cells 
highly express Blimp-1 in addition to Foxp3 (Cretney et al., 
2013). From PCs it is known that Blimp-1 represses CXCR5, 
which is a requisite to egress from GCs (Shaffer et al., 2002). 
Similarly, Blimp-1 deletion (Linterman et al., 2011) led to an up-
regulation of CXCR5, whereas overexpression of Blimp-1 
repressed CXCR5 (Oestreich et al., 2012). One possibility 
also supported by our preliminary data could be that NFAT2 
specifically overcomes the Blimp-1–mediated repression in 
TFR cells. In such a scenario, this molecular checkpoint would 
be controlled by an inhibiting (i.e., Blimp-1) and activating 
(i.e., NFAT2) factor, which ensures an adequate expression of 
CXCR5, and thereby an appropriate GC response. A mutual 
balancing of Blimp-1 and NFAT2 might even culminate in 
synergy. At least this has been described for eTreg cells, where 
Blimp-1 in conjunction with IRF4 acts as a positive regulator 
at the Il10 intron1 enhancer (Cretney et al., 2011).
the mesangial matrix in kidney sections of NFAT2-deficient 
mice (Fig. 9 D). Furthermore, detection of pathogenic immuno-
globulin deposition in the kidneys was indicative of an ag-
gravated lupuslike disease in chromatin-immunized Nfat2fl/fl x 
Cd4cre mice (Fig. 9 E). All these data demonstrate that NFAT2 
is essential for TFR cells to control humoral autoimmunity.
DISCUSSION
Earlier transcriptional profiling of CD4+ICOShiCXCR5hi 
TFH cells from chronically inflamed tonsils identified Nfat2  
as one of the most prominently up-regulated genes (Rasheed 
et al., 2006). When we now analyzed murine TFH cells we found 
a similar prevalence of NFAT2 among transcription factors 
in general and NFAT members especially. Immunization of 
mice, in which Nfat2 was specifically ablated in T cells, re-
sulted in an unexpected phenotype, i.e., an enhanced GC re-
action. This could be tracked down to an impairment of 
Foxp3+ Treg cells to up-regulate CXCR5, leading to reduced 
numbers of Foxp3+ TFR cells within GCs. NFAT2-dependent 
CXCR5 up-regulation and consequential homing to GCs was 
TFR cell–intrinsic as well as specific. Furthermore, rescue experi-
ments verified that the inability to induce CXCR5 in nTreg cells 
accounted for the observed phenotype. Therefore, absence of 
NFAT2 was sufficient to exclude TFR cells from GCs. The out-
standing importance for precise homing of CXCR5hiFoxp3+ 
TFR cells was emphasized in a murine model of a lupuslike dis-
ease with a boosted severity in the absence of NFAT2.
One possible interpretation of the enhanced GC reaction 
upon Nfat2 ablation in T cells might have taken into account 
that NFAT proteins are decisive transactivators of Il2 and 
that less IL-2 favors GC formation (Ballesteros-Tato et al., 
2012; Johnston et al., 2012). However, (a) single deficiency of 
NFAT2 does not dramatically reduce the levels of IL-2 (Vaeth 
et al., 2012), (b) we confirmed the increase of TFH and GC-B 
cells after Treg-specific deletion of Nfat2, (c) demonstrated the 
reduction of CXCR5 on Treg cells as cell-intrinsic by co-
transferred WT and Nfat2/ CD4+ T cells, and (d) were able 
to rescue the overshooting GC reaction in Nfat2fl/fl x Cd4cre 
mice by transfer of CXCR5-sufficient WT nTregcells.
Still, the phenotype of T cell–specific Nfat2 ablation, 
which is dominated by Nfat2/ Treg cells, was unexpected, as 
we had revealed that overall frequency and distribution of 
nTreg cells remains unaltered in mice that were NFAT2-deficient 
upon thymic CD4 expression (Vaeth et al., 2012). However, 
the observed augmented GC formation correlated with an 
exclusive decrease in TFR cells and could be reversed by an 
adoptive transfer of WT and NFAT2-deficient, but CXCR5-
sufficient, nTreg cells. Consistently, nTreg cells were selectively 
affected in up-regulating the chemokine receptor CXCR5. 
CXCR5 empowers T cells to migrate toward a CXCL13 gra-
dient and accumulate site-specifically within GCs. This is 
reminiscent of expression of the Th1-defining transcription 
factor T-bet in nTreg cells, leading to CXCR3 induction and 
migration to sites of Th1 responses, or of STAT3 induction 
for adapting CCR6 expression like Th17 cells (Chaudhry et al., 
2009; Josefowicz et al., 2012; Koch et al., 2009). Therefore, 
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Figure 9. NFAT2-deficient Foxp3+ regulatory T cells fail to control a lupuslike disease in chromatin-immunized mice. (A) Schedule of PBS and 
chromatin immunization to provoke a lupuslike disease in WT littermate and Nfat2fl/fl x Cd4cre mice. (B) Flow cytometry of CXCR5–PD-1– conventional, 
CXCR5hiPD-1hi follicular T cells, and GC-B cells in spleens of immunized mice. WT and Nfat2fl/fl x Cd4cre littermates were immunized with PBS in CFA (PBS 
ctrl.) or chromatin in CFA and analyzed 8 wk after first immunization. (C) ELISA for dsDNA-specific total immunoglobulins (top) and IgG (bottom) in sera 
of PBS or chromatin immunized WT littermate and Nfat2fl/fl x Cd4cre mice. Sera from 5 individual mice were analyzed 8 wk after first immunization. Stu-
dent’s t test: *, P < 0.05; **, P < 0.005. (D) PAS staining of kidney samples from PBS in CFA (PBS ctrl.) or chromatin in CFA-immunized WT and Nfat2fl/fl x 
Cd4cre mice 25 wk after immunization. Bars, 50 µm. (E) Histological analysis of immunoglobulin deposition in kidneys of WT and Nfat2fl/fl x Cd4cre litter-
mates 25 wk after PBS or chromatin immunization. Bars, 50 µm.
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et al., 2005). In brief, chromatin was isolated from syngenic BL/6 spleno-
cytes stimulated for 2 d in complete RPMI with T/I. After washing, nuclei 
were extracted, washed, and lysed in buffer containing 300 mM NaCl, 
25 mM EDTA, 50 mM Tris-HCl, pH 8.0, 0.2% SDS, and 0.5 mg/ml Pro-
teinase K (Fermentas) overnight at 50°C. Chromatin was precipitated with 
EtOH, dried, and digested by incubation with S1 Nuclease (Fermentas) for 
60 min at 30°C in the respective buffer. The reaction was stopped by addi-
tion of 40 mM EDTA for 15 min at 70°C and the chromatin was finally 
precipitated with EtOH, dried, and resolved in PBS at 1 µg/µl concentration. 
Mice were immunized subcutaneously (s.c.) with 100 µg chromatin in 100 µl 
CFA (Difco) and the immune reaction was boosted with additional s.c. injec-
tion of 100 µg chromatin in IFA (Difco) in the 1st, 3rd, and 23rd week.
Antibodies for flow cytometry and FACS-sorting. FACS staining was 
performed with following Abs: FITC-conjugated CD4 (GK1.5), CD44 
(IM7), CD90.1 (OX-7), CXCR4 (2B11), GL-7 (Ly-77); PE-conjugated 
CD4 (RM4-5), CD19 (1D3), CD25 (PC61), CD95/Fas (DX2), CD272/
BTLA (8F4), CD279/PD-1 (RMP1-30), CXCR5 (2G8); biotin-conjugated 
B220 (RA3-6B2), CD4 (GK1.5) CD90.2 (53–2.1), CXCR5 (SPRCL5), 
ICOS (7E.17G9); eFluor 450-conjugated CD4 (RM4-5), GL-7 (Ly-77); 
and secondary streptavidin-APC, streptavidin-PE, or streptavidin-PE-Cy5.5 
mAbs (all BD or eBioscience). Intracellular Foxp3 (FJK-16s, FITC-, and APC-
conjugated) staining was performed using the Foxp3 staining kit (eBioscience). 
Samples were analyzed on a FACSCanto II (BD) with FlowJo software (Tree 
Star). FACS sorting was performed with the FACS Aria cell sorter (BD).
Immunofluorescence and immunohistochemistry. For confocal mi-
croscopy, FACS-sorted cells were harvested on slides using cytospin. Cells 
were fixed and permeabilized with the Foxp3 staining kit (eBioscience). For 
tissue samples, formalin-fixed paraffin-embedded specimens were prepared 
(Vaeth et al., 2012). Immunohistochemical reactions were prepared using 
heat-induced antigen retrieval performed under pressure in citrate-buffer 
(pH 6.0; Sigma-Aldrich). The following primary antibodies were used: rabbit 
anti-NFAT1 (Sigma-Aldrich), mouse anti-NFAT2 (7A6; BD), rabbit anti-
NFAT2/ (IG-457; immunoGlobe), mouse anti-NFAT4 (F-1; Santa Cruz 
Biotechnology, Inc.), mouse anti-CD3e (PS1; Leica), PNA-biotin (Vector 
Laboratories), rabbit anti-Ig (Dako), and rat anti-Foxp3 (FJK-16s, eBiosci-
ence). Secondary staining was performed using the following Abs: anti–rabbit 
Alexa Fluor 647, anti–mouse Alexa Fluor 488, and anti–rat Alexa Fluor 555 
(all from Molecular Probes); anti–IgM-Cy5 (Jackson ImmunoResearch 
Laboratories); and streptavidin-Alexa Fluor 488 (Invitrogen). Slides were 
mounted with Fluoromount-G (SouthernBiotech) containing DAPI. Images 
were taken with a confocal microscope (TCS SP2 equipment, objective lens; 
HeX PL APO, 40×/1.25-0.75; Leica) and LCS software (Leica). For statistics, 
>30 cells from at least 2 independent experiments were counted and mean 
fluorescence intensity per cell (MFI) was calculated. For immunohistochem-
istry, anti–rabbit HRP (Dianova), anti–rat HRP (Abcam), and Neutravidin 
HRP (Dianova) were used as secondary Abs. Hematoxylin and eosin staining 
and PAS staining were performed as previously described (Vaeth et al., 2012).
Real-time PCR. RNA was extracted using RNeasy Micro kit (QIAGEN) 
followed by cDNA synthesis with the iScript II kit (Bio-Rad Laboratories). 
Real-time qRT-PCR was performed with an ABI Prism 7700 detection sys-
tem using following primers: Nfat2, 5-GATCCGAAGCTCGTATGGAC-3  
plus 5-AGTCTCTTTCCCCGACATCA-3; Nfat1, 5-TCATAGGAG-
CCCGACTGATTG-3 plus 5-CCATTCCCATCTGCAGCAT-3; Nfat4, 
5-GCCTCCATTGACAGAGCAACT-3 plus 5-CACATCCCACAGC-
CCAGTG-3; Nfat2 P1, 5-CGGGAGCGGAGAAACTTTGC-3 plus 
5-CAGGGTCGAGGTGACACTAG-3; Nfat2 P2, 5-AGGACCCGGA-
GTTCGACTTC-3 plus 5-CAGGGTCGAGGTGACACTAG-3; Foxp3, 
5-GGCCCTTCTCCAGGACAGA-3 plus 5-GCTGATCATGGCTGG-
GTTGT-3; Bcl6, 5-GATACAGCTGTCAGCCGGG-3 plus 5-AGTT-
TCTAGGAAAGGCCGGA-3; Prdm1, 5-TAGACTTCACCGATGAG-
GGG-3 plus 5-GTATGCTGCCAACAACAGCA-3; Cxcr5, 5-TCCTG-
TAGGGGAATCTCCGT-3 plus 5-ACTAACCCTGGACATGGGC-3; 
Hprt, 5-AGCCTAAGATGAGCGCAAGT-3 plus 5-TTACTAGGCA-
GATGGCCACA-3.
Treg cells can directly suppress B cells in GCs and periph-
ery (Lim et al., 2005; Vaeth et al., 2011; Sage et al., 2013), 
where Treg-derived IL-10 and the GITR are functionally 
involved (Alexander et al., 2011). In addition, we found that 
direct cell–cell contact enables the transfer of cAMP (cyclic 
adenosine monophosphate) from Treg into B cells via gap-
junction intracellular communication, resulting in the induc-
tion of ICER (inducible cAMP early repressor; Bopp et al., 
2007; Vaeth et al., 2011; Bodor et al., 2012). ICER is a tran-
scriptional repressor, which inhibits lymphocyte activation 
not only by interfering with Nfat2 expression directly, but 
also the suppression of NFAT-mediated transcription (Vaeth 
et al., 2011; Bodor et al., 2012). Because GC-B cells require 
high levels of NFAT2 for GC formation and the production of 
class-switched, high-affinity Abs (Bhattacharyya et al., 2011), 
the inhibition of NFAT in target cells appears as an additional 
mechanism in how TFR cells regulate GC reaction.
In summary, NFAT2 is instrumental for both an adequate 
and nonpathological humoral immune response. Whereas 
NFAT2 is of importance for GC-B and TFH cells (Rasheed 
et al., 2006; Bhattacharyya et al., 2011), it is concomitantly 
needed to limit the GC reaction by TFR cells. NFAT2 regu-
lates the specific homing of TFR cells to GCs via up-regulating 
CXCR5, essentially to prevent humoral autoimmune diseases 
like SLE.
MATERIALS AND METHODS
Mice and cells. Nfat2fl/fl mice were generated in A. Rao’s laboratory (Har-
vard Medical School, Boston, MA). Phenotypes, when crossed to Cd4cre and 
FIC, have been explored earlier and proof of NFAT2 deficiency had previ-
ously been provided on genetic and protein levels for all T cells including 
nTreg cells (Vaeth et al., 2012). Nfat1/, Nfat4/, B6-Tg (Cd4cre) 1Cwi/
Cwilbcm (EMMA, Italy), Foxp3-IRES-cre (FIC), OT-II, Rag1/, Nfatc1/egfp, 
and Foxp3DTR-eGFP (DEREG) mice have been described (Barnden et al., 
1998; Ranger et al., 1998; Lee et al., 2001; Jasinski et al., 2006, Lahl et al., 
2007; Wing et al., 2008; Hock et al., 2013). Animals were used at 6 to 16 wk 
and maintained in accordance with institutional guidelines for animal welfare. 
Jurkat, EL-4, and HEK 293T cells were cultured in complete RPMI or DMEM 
medium containing 10% FCS (Nayak et al., 2009; Vaeth et al., 2012).
Immunizations, Treg depletion, and adoptive cell transfer. Sex-
matched littermate mice were immunized (approval by the government of 
Lower Franconia; 55.2–2531.01-80/10) intraperitoneally (i.p.) with 100 µg 
NP-(27)-KLH (BioCat) emulsified in Imject Alum (Thermo Fisher Scien-
tific) or 109 SRBCs (Dunn Labortechnik) and analyzed on d 7. In some ex-
periments, mice were boosted with 50 µg NP-(27)-KLH on day 7 and ana-
lyzed on d 10–12. OT-II mice were immunized i.p. with 100 µg OVA323-339 
emulsified in Imject Alum. Depletion of Foxp3+ Treg cells in Foxp3DTR-eGFP 
(DEREG) mice was performed by daily injection of 1 µg diphtheria toxin 
(DT) in PBS i.p. on day 1–3 after KLH immunization. For adoptive cell 
transfer experiments, 12 × 106 negatively isolated WT B cells (Miltenyi Bio-
tec) were transferred along with 6 × 106 WT negatively isolated (Invitrogen) 
CD90.1+CD4+ T cells and 6 × 106 CD90.1+CD4+ Nfat2fl/fl x Cd4cre T cells 
i.p. into Rag1/ mice. After 28 d mice were immunized with 100 µg NP-
(27)-KLH. For rescue experiments, CD90.1+CD4+CD25+ WT nTreg cells 
were isolated and activated with anti-CD3/CD28 beads (Invitrogen). 7 d 
after immunization, 5 × 106 nTreg cells were injected retroorbitally into 
CD90.2+ WT and Nfat2fl/fl x Cd4cre littermates.
Chromatin immunization. Induction of a lupuslike disease by chromatin 
immunization was performed as reported by others (Li et al., 2004; Qiao 
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Reporter gene assays. HEK 293T cells, Jurkat T, or EL-4 cells were tran-
siently transfected with different Cxcr5 promoter luciferase-reporter con-
structs alone or in combination with a plasmid encoding for NFAT2/C 
using calcium phosphate, Superfect reagent (Invitrogen), and DEAE dextran, 
respectively. 36 h after transfection, luciferase activity was measured from the 
cells that were left untreated, treated with T/I or T/I plus CsA overnight and 
relative light units were corrected for the transfection efficacy due to total 
protein concentrations. Normalized mean values of at least three indepen-
dent experiments are depicted in relative light units as fold activation over 
empty vector control.
Lentiviral transduction of primary nTreg cells and adoptive transfer 
experiments. Primary CD4+CD25+ nTreg cells from WT and Nfat2fl/fl x 
Cd4cre mice were activated with anti-CD3/CD28 beads (Invitrogen) for 3 d 
in presence of 50 U/ml IL-2. Beads were removed and 5 × 106 nTreg cells 
were collected and resuspended in 1 ml fresh RPMI medium containing 
8 µg/ml polybrene (Santa Cruz Biotechnology) and 50 U/ml lL-2 (Pepro-
Tech). After 30 min, cells were centrifuged and the supernatant was 
mostly removed. Cell pellets were resuspended in 0.25 ml/2.5 × 106 IFU 
ready-made lentiviral solution (gfp or Cxcr5-gfp [pLenti-EF1a(mCXCR5)-
Rsv(GFP-Puro)]; Amsbio) and transduction was performed by spin infection 
(1,800 rpm for 90 min at 32°C). Then cells were diluted in 2 ml RPMI 
medium containing 50 U/ml lL-2 (PeproTech) and incubated for additional 
4 h at 37°C. In the meantime, CD4+CD25–CD62Lhi T cells and B cells were 
isolated from WT mice using the naive T cell isolation kit and the untouched 
B cell isolation kit, respectively (Miltenyi Biotec). nTreg cells were washed 
twice and 4 × 105 transduced WT or NFAT-deficient nTregcells along with 
5 × 106 B cells and 2 × 106 naive T cells were adoptively transferred i.p. into 
Rag1/ mice. After 14 d, mice were immunized with 100 µg NP-KLH and 
analyzed on day 21.
Statistical analysis. Results were compared with Prism software (Graph-
Pad) using two-tailed paired or unpaired Student’s t test and two-way 
ANOVA. Differences with p-values of <0.05 are considered significant: 
*, P < 0.05; **, P < 0.005; ***, P < 0.001.
Online supplemental material. Fig. S1 shows a scheme of the Cxcr5 pro-
moter region. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20130604/DC1.
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 SUPPLEMENTAL MATERIAL 
 Vaeth et al., http://www.jem.org/cgi/content/full/jem.20130604/DC1 
 Figure S1. Scheme of  Cxcr5 promoter region. (A) Alignment of human and dog  Cxcr5 promoter reveals conserved noncoding sequences (CNS). (B) 
DNA sequence alignment of murine and human  Cxcr5 promoter shown in A. Potential binding sites of NFAT, constructs used in reporter gene assays, and 
primers for ChIP experiments are illustrated. (C) Identifi cation of potential regulatory elements (HS2 and HS1) within the  Cxcr5 gene using public DNase I 
mapping data. (D) Sequence of the  Cxcr5 promoter; starting nucleotides for luciferase constructs in purple, probes used for EMSA underlined and names 
given at the side. The GG→AA mutation within  Cxcr5-N1 (red) is shown below. 
